| Product Name | MF | CAS | Details |
|---|
| Phthalamic Acid | C22H25NO6 | 6901-14-0 | Details |
| Tofacitinib Citrate | C22H34N4O3 | 2975124-11-7 | Details |
| (R)-Amlodipine | C21H21NO4S | 3038592-01-4 | Details |
| 2-hydroxy-8-(methylthio)butanamide | C8H18N2O | 5350-17-4 | Details |
| Baricitinib Impurity I | C21H26Cl2N2O3 | 163837-48-7 | Details |
| Lactate tetramer | C6H4ClFOS | 50986-83-9 | Details |
| (R)-Amlodipine | C17H23ClN4S2 | 570407-42-0 | Details |
| Ezetimibe (SSR)-Isomer | C20H18NO5 | 5058-45-7 | Details |
| Linagliptin Impurity CD10091 | C42H36ClN3O5 | 1580889-36-6 | Details |
| Rosuvastatin EP Impurity A | C25H40ClN3O8 | 1253907-83-3 | Details |
| Deubutafrazine Impurity | C23H38O | 3879-23-0 | Details |
| Rosuvastatin EP Impurity A | C16H21N3O2 | 313369-17-4 | Details |
| Fulvestrant Impurity I | C23H38O | 3796-64-3 | Details |
| DL-Methionine Sulfoxide | C31H40O3 | 65061-22-5 | Details |
| Linagliptin Impurity CD10094 | C21H33NO2 | 106614-69-1 | Details |
| Ezetimibe (SSR)-Isomer | C14H17ClN2O4 | 931395-73-2 | Details |
| Vitamin B6 Impurity 57 | C11H14O2 | 134747-45-8 | Details |
| Lactate tetramer | C14H20O | 106614-66-8 | Details |
| Varenicline Impurity D | C6H8ClN3O3 | 109620-80-6 | Details |
| Phthalamic Acid | C22H15FN6O | 1029713-99-2 | Details |
| Rosuvastatin EP Impurity A | C15H16N2O | 1466-67-7 | Details |
| Nintedanib Impurity 31 | C29H46O5 | 5951-83-7 | Details |
| DL-Methionine Sulfoxide | C9H10O4S | 197240-27-0 | Details |
| 2-hydroxy-58-(methylthio)butanamide | C6H9N3O2 | 4998-57-6 | Details |
| DL-Methionine Sulfoxide | C34H38N8O9 | 52434-75-0 | Details |
| Vitamin B6 Impurity 106 | C8H9Br | 1585-07-5 | Details |
| Baricitinib Impurity I | C11H18ClNO2 | 5178-52-9 | Details |
| N-Nitroso Furosemide | C16H16F5N5O | 486459-88-5 | Details |
| 2-hydroxy-6-(methylthio)butanamide | C4H4O4 | 110-16-7 | Details |
| 4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-6-formamidopyrimidine-5-carboxylic acid | C17H20N6O4S | 2402776-80-9 | Details |
| 2-hydroxy-5-(methylthio)butanamide | C24H28Cl2F3NO4 | 1095275-08-3 | Details |
| Linagliptin Impurity CD10093 | C31H48O5 | 1013937-16-0 | Details |
| Valsartan Methyl Ester | C13H21NO | 351329-88-9 | Details |
| N-Nitroso Furosemide | C5H6N4O2S | 1450758-21-0 | Details |
| 1,3-dimethyl-4-nitrosourea | C15H16ClN | 134865-58-0 | Details |
| Deubutafrazine Impurity | C44H54CaF2N6O12S2 | 854898-49-0 | Details |
| 2-hydroxy-9-(methylthio)butanamide | C29H44O4 | 13011-12-6 | Details |
| Linagliptin Impurity CD10090 | C56H80O2 | 523-39-7 | Details |
| DL-Methionine Sulfoxide | C29H34Cl2N6O4S2 | 2681355-40-6 | Details |
| Ezetimibe (SSR)-Isomer | C21H25ClN2O3 | 130018-76-7 | Details |
| Noradrenaline Impurity 18 | C15H16ClN | 387383-30-4 | Details |
| Cilnidipine Impurity 62 | C9H17NO3 | 101469-92-5 | Details |
| Rosuvastatin EP Impurity A | C23H24N4O3 | 1306760-87-1 | Details |
| Varenicline Impurity D | C10H15NO2 | 120-20-7 | Details |
| Varenicline Impurity D | C17H21N3O3 | 313369-25-4 | Details |
| Lactate tetramer | C12H13N | 10420-89-0 | Details |
| Linagliptin Impurity CD10089 | C14H23NO4 | 1385767-85-0 | Details |
| Nintedanib Impurity 29 | C18H25N4NaO17P2 | 221169-12-6 | Details |
| Tofacitinib Citrate | C37H41FN2O5 | 1353049-81-6 | Details |
| Fulvestrant Impurity I | C11H15NO3.ClH | 16899-81-3 | Details |
| Fulvestrant Impurity I | C23H26Cl3N5O2S2 | 570403-05-3 | Details |
| Lactate tetramer | 1415561-33-9 | Details |
| 1,3-dimethyl-5-nitrosourea | C28H32N4O5 | 1306763-64-3 | Details |
| Baricitinib Impurity I | C9H19NO2 | 287395-61-3 | Details |
| Nintedanib Impurity 27 | C8H9N3O4 | 91828-74-9 | Details |
| Lactate tetramer | C11H18N2O3 | 2432911-31-2 | Details |
| 1,3-dimethyl-55-nitrosourea | C22H36O2 | 1264737-31-6 | Details |
| Varenicline Impurity D | C18H28N4O | 101954-22-7 | Details |
| Linagliptin Impurity CD10142 | C7H10ClN | 636-21-5 | Details |
| (R)-Amlodipine | C25H29BFN3O8 | 849770-49-6 | Details |
| Valsartan Methyl Ester | C3H4Cl2 | 10061-02-6 | Details |
| (R)-Amlodipine | C21H23NO6 | 7411-12-3 | Details |
| 2-hydroxy-10-(methylthio)butanamide | C9H19N3O6 | 14169-16-5 | Details |
| Varenicline Impurity D | C25H40ClN3O8 | 1253907-81-1 | Details |
| Rosuvastatin EP Impurity A | C4H6O3 | 541-50-4 | Details |
| Fulvestrant Impurity I | C11H15NO3 | 98496-30-1 | Details |
| DL-Methionine Sulfoxide | C29H44O4 | 4701-54-6 | Details |
| Lactate tetramer | C8H8O2 | 99-93-4 | Details |
| Tofacitinib Impurity FD+DX | C29H47NaO5 | 55601-53-1 | Details |
| Phthalamic Acid | C35H42N4O5 | 909800-36-8 | Details |
| Valsartan Methyl Ester | C15H22N2O | 92623-85-3 | Details |
| Baricitinib Impurity I | C10H16N2O5 | 38821-49-7 | Details |
| Cilnidipine Impurity 11 | C16H19N3O3 | 313369-16-3 | Details |
| Tofacitinib Citrate | C16H24BrNO2 | 1708930-15-7 | Details |
| Fulvestrant Impurity I | C31H46O6 | 4680-37-9 | Details |
| Tofacitinib Impurity FD+DX | C24H26Cl2N4O4 | 1253852-50-4 | Details |
| Fulvestrant Impurity I | C17H17NO3 | 24833-47-4 | Details |
| Noradrenaline Impurity 16 | C24H25FO7S | 2639148-36-8 | Details |
| Tofacitinib Impurity FD+DX | C13H10BrN | 320345-99-1 | Details |
| Tofacitinib Citrate | C36H41FN2O5 | 1035205-25-4 | Details |
| Phthalamic Acid | C14H17BrN2O2 | 1059630-08-8 | Details |
| Tofacitinib Citrate | C7H8ClN3O2 | 1384752-15-1 | Details |
| Vitamin B6 Impurity 56 | C9H22O6P2 | 1660-94-2 | Details |
| 1,3-dimethyl-3-nitrosourea | C11H8N2O6 | 1202160-40-4 | Details |
| Noradrenaline Impurity 69 | C22H36O2 | 38398-32-2 | Details |
| Rosuvastatin EP Impurity A | C6H6N4O3 | 605-99-2 | Details |
| Noradrenaline Impurity 19 | C10H17N3O8S | 17297-99-3 | Details |
| Cilnidipine Impurity 13 | C19H17N5O2 | 82956-09-0 | Details |
| N-(2-(4-amino-3,5-dichlorophenyl)-2-oxoethyl)-N-(tert-butyl)nitrous amide | C16H20BrN3O3 | 1059630-09-9 | Details |
| Linagliptin Impurity CD10092 | C9H20ClNO2 | 625120-81-2 | Details |
| Tofacitinib Impurity FD+DX | C16H17N7O2S | 2402776-83-2 | Details |
| Ezetimibe (SSR)-Isomer | C5H13O5P | 2489782-66-1 | Details |
| 2-hydroxy-59-(methylthio)butanamide | C11H13NO3 | 73853-05-1 | Details |
| Tofacitinib Citrate | C12H22O11 | 20869-27-6 | Details |
| Lactate tetramer | C31H46O5 | 74048-41-2 | Details |
| Tofacitinib Impurity FD+DX | C20H36N2O6 | 229614-05-5 | Details |
| Phthalamic Acid | C31H50O8 | 80445-74-5 | Details |
| Cilnidipine Impurity 9 | C6H3ClFNO2 | 350-30-1 | Details |
| Lactate tetramer | C31H29ClN6O6 | 2613141-84-5 | Details |
| Tofacitinib Citrate | C21H18Cl2N2O4 | 70894-66-5 | Details |
| Product Total： Product Page： | ||||
| 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 | ||||